Evidence map›Paper›PMID 35292841›Full record

ArticleActa neurochirurgica2022

How I do it: endonasal transcribriform approach for resection of esthesioneuroblastoma.

J Curran Henson, Amarbir Gill, Jeremiah Alt, Michael J Karsy

Abstract readCase Reports
PubMed Publisher
In one paragraph

Article in Acta neurochirurgica, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.4field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 2 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

J Curran HensonCollege of Medicine, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
Amarbir GillDivision of Otolaryngology, University of Utah, Salt Lake City, UT, USA.
Jeremiah AltDivision of Otolaryngology, University of Utah, Salt Lake City, UT, USA.
Michael J KarsyDepartment of Neurosurgery, Clinical Neurosciences Center, University of Utah, 175 N. Medical Drive East, Salt Lake City, UT, 84132, USA. michael.karsy@hsc.utah.edu.ORCID http://orcid.org/0000-0002-0422-7937
University of Utah · USUniversity of Arkansas for Medical Sciences · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundOlfactory neuroblastoma, also known as esthesioneuroblastoma, accounts for only 3-6% of sinonasal malignancies but confers a 40% 5-year overall survival.

methodThe authors describe techniques for the endonasal, minimally invasive resection of an esthesioneuroblastoma in a 69-year-old man who presented with headaches and anosmia and describe surgical nuances and their effect on adjuvant therapy planning.

conclusionThis approach, along with microsurgical techniques, helped increase tumor visualization, improved marginal resection, and reduced surgical risk, which may improve patient outcomes. Multilayered reconstruction with a synthetic dural substitute and creation of a nasoseptal flap were performed to reduce postoperative cerebrospinal fluid leak.

Indexed as

Esthesioneuroblastoma, OlfactoryNose NeoplasmsPlastic Surgery ProceduresAgedEndoscopyHumansMaleNasal CavityRetrospective StudiesSkull BaseSurgical FlapsEndoscopicEsthesioneuroblastomaMinimally invasiveOlfactory neuroblastoma

Identifiers

PMID35292841
OpenAlexW4220791797

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.